The Study of Polyethyleneglycol-Coated Liposomes Containing CPT-11

References

• Gabizon A., Goren D., Barenholz Y. Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor models. Isr. J. Med. Sci. 1988; 24: 512–517
   PubMedGoogle Scholar
• Mayhew E., Cimino M., Klemperer J., Razo R., Wiernikowski J., Arbuck S. Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor. Therapeutic and pharmacologic studies. Select. Cancer Ther. 1990; 6(4)193–209
   Google Scholar
• Balazsovits J. A. E., Mayer L. D., Bally M. B., Cullis P. R., Ginsberg R. S., Falk R. E. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother. Pharmacol. 1989; 23: 81–86
   PubMed Web of Science ®Google Scholar
• Sawada S., Okajima S., Aiyama R., Nokota K., Furuta T., Yokokura T., Sugini E., Yamaguchi K., Miyasaka K. Synthesis and antitumor activity of 20(s)-camptotecin derivatives. Carbomate-linked, water-soluble derivartives of 7-ethyl-10-hydroxy-camptothecin. Chem. Pharm. Bull. 1991; 39(6)1446–1454
   Google Scholar
• Kawato Y., Aonuma M., Hirota Y., Kuga H., Sato K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 1991; 51(16)4187–4191
   PubMed Web of Science ®Google Scholar
• Tsuji T., Kaneda N., Kado K., Tokokura T., Yoshimoto T., Tsuru D. CPT-11 converting enzyme from rat serum. Purification and some properties. J. Pharmacobiodyn. 1991; 14(6)341–349
   Google Scholar
• Kawato Y., Furuta T., Aonuma M., Yokokura T., Matsumoto K. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother. Pharmacol. 1991; 28(3)192–198
   Google Scholar
• Kudoh S., Takada M., Masuda N., Nakagawa K., Itoh K., Kusunoki Y., Negri S., Matsui K., Takifuji K., Morino H., Fukuoka M. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts. Jpn. J. Cancer. Res 1993; 84: 203–207
   PubMedGoogle Scholar
• Nishimura G., Satou T., Yoshimitsu Y., Kurosaka Y., Fujimura T., Sugiyama K., Kanno M., Yonemura Y., Miwa K., Miyazaki I. Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer. Jpn. J. Cancer Chemother. 1995; 22(1)93–97
   Google Scholar
• Sadzuka Y., Nakai S., Miyagishima A., Nozawa Y., Hirota S. The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. J. Drug Targeting 1995; 3: 31–37
   PubMed Web of Science ®Google Scholar
• Kono A., Hara Y. Conversion of CPT-11 into SN-38 in human tissues. Jpn. J. Cancer Chemother. 1991; 18(12)2175–2178
   Google Scholar
• Barilero I., Gandia D., Armand J. P., Mathien-Bone A., Re M., Gouyette A., Chabot G.G. Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography, application to plasma pharmacokinetics studies in cancer patients. J. Chromatogr. 1992; 575: 275–280
   PubMed Web of Science ®Google Scholar
• Hirotsu S., Sadzuka Y., Miyagishima A., Nozawa Y., Hirota S. The preparation and the tissue distribution of liposomal CPT-II. Drug Delivery System 1995; 10(4)283
   Google Scholar
• Taguchi T., Wakui A., Hasegawa K., Niitani H., Furue H., Ohta K., Hattori T. Phase I clinical study of CPT-11. Research group of CPT-11. Jpn. J. Cancer Chemother. 1990; 17(1)115–120
   Google Scholar
• Shimada K., Miyagishima A., Sadzuka Y., Nozawa Y., Mochizuki Y., Ohshima H., Hirota S. Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes. J. Drug Targeting 1995; 3: 283–289
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Kasi L., Rosenblum M. G., Haynie T., Jahns M., Glenn H., Mehta R., Mavlight G. M., Hersh E. M. Distribution and pharmacology of intravenous tecnetium-99m-labeled multilamellar liposomes in rats and mice. Cancer Res. 1984; 44: 375–378
   PubMed Web of Science ®Google Scholar
• Klibanov A. L., Maruyama K., Torchilin V. P., Huang I. Amphipathic polyethyleneglycols effectively prolong circulation time. FEBS Lett. 1990; 268: 235–237
   PubMed Web of Science ®Google Scholar
• Allen T. M., Chonn A. Large unilameller liposomes with low uptake into reticuloendothelial system. FEBS Lett. 1987; 223: 42–46
   PubMed Web of Science ®Google Scholar
• Mi Z., Burke T. G. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 1994; 33(34)10325–10336
   PubMed Web of Science ®Google Scholar
• Sasaki Y., Yoshida Y., Sudoh K., Hakusui H., Fujii H., Ohtsu T., Wakita H., Igarashi T., Itoh K. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11. Jpn. J. Cancer Res. 1995; 86: 111–116
   PubMedGoogle Scholar